G. Walmsley Graham, Director at Akero Therapeutics, Inc. (AKRO), bought 400,000 shares at $26.00 ($10.4M) on 2023-09-19, disclosed to the SEC on 2023-05-23.
Open-market purchase of $10.4M AKRO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
The price or value on this filing does not reconcile with what the stock was worth on the trade date, and we could not determine the right figure. Read the numbers above as reported, not as confirmed. This filing is excluded from every total on the site.
Read the original on SEC EDGAR →| Filing → |
| OLMA | SELL | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-17 | $4.7M | — | Filing → |